Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis
Author:
Affiliation:
1. Merrimack Pharmaceuticals, One Kendall Square, Building 700, Cambridge, MA 02139, USA.
Abstract
Publisher
American Association for the Advancement of Science (AAAS)
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference76 articles.
1. Targeting ERBB Receptors in Cancer
2. The ErbB receptors and their role in cancer progression
3. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
4. The EGF receptor family: spearheading a merger of signaling and therapeutics
5. ERBB receptors and cancer: the complexity of targeted inhibitors
Cited by 328 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathway;PLOS Computational Biology;2024-02-05
2. Efficient parameter estimation for ODE models of cellular processes using semi-quantitative data;2024-01-30
3. Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis;Molecular Pharmaceutics;2023-11-16
4. Posterior marginalization accelerates Bayesian inference for dynamical models of biological processes;iScience;2023-11
5. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer;Cells;2023-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3